163 related articles for article (PubMed ID: 36325962)
1. The association between low skeletal muscle mass and low skeletal muscle radiodensity with functional impairment, systemic inflammation, and reduced survival in patients with incurable cancer.
Calixto-Lima L; Wiegert EVM; Oliveira LC; Chaves GV; Bezerra FF; Avesani CM
JPEN J Parenter Enteral Nutr; 2023 Feb; 47(2):265-275. PubMed ID: 36325962
[TBL] [Abstract][Full Text] [Related]
2. Is skeletal muscle radiodensity able to indicate physical function impairment in older adults with gastrointestinal cancer?
Barbalho ER; Gonzalez MC; Bielemann RM; da Rocha IMG; de Sousa IM; Bezerra RA; de Medeiros GOC; Fayh APT
Exp Gerontol; 2019 Oct; 125():110688. PubMed ID: 31404625
[TBL] [Abstract][Full Text] [Related]
3. Skeletal muscle radiodensity is prognostic for survival in patients with advanced non-small cell lung cancer.
Sjøblom B; Grønberg BH; Wentzel-Larsen T; Baracos VE; Hjermstad MJ; Aass N; Bremnes RM; Fløtten Ø; Bye A; Jordhøy M
Clin Nutr; 2016 Dec; 35(6):1386-1393. PubMed ID: 27102408
[TBL] [Abstract][Full Text] [Related]
4. Skeletal Muscle Quality Beyond Average Muscle Attenuation: A Proposal of Skeletal Muscle Phenotypes to Predict Short-Term Survival in Patients With Endometrial Cancer.
Rodrigues CS; Chaves GV
J Natl Compr Canc Netw; 2018 Feb; 16(2):153-160. PubMed ID: 29439176
[No Abstract] [Full Text] [Related]
5. Clinical significance of skeletal muscle density and sarcopenia in patients with pancreatic cancer undergoing first-line chemotherapy: a retrospective observational study.
Kim IH; Choi MH; Lee IS; Hong TH; Lee MA
BMC Cancer; 2021 Jan; 21(1):77. PubMed ID: 33461517
[TBL] [Abstract][Full Text] [Related]
6. Muscle radiodensity loss during cancer therapy is predictive for poor survival in advanced endometrial cancer.
Lee J; Lin JB; Wu MH; Jan YT; Chang CL; Huang CY; Sun FJ; Chen YJ
J Cachexia Sarcopenia Muscle; 2019 Aug; 10(4):814-826. PubMed ID: 31094101
[TBL] [Abstract][Full Text] [Related]
7. Factors associated with variability in skeletal muscle radiodensity in patients with metastatic cancer.
Calixto-Lima L; Wiegert EVM; de Oliveira LC; Chaves GV; Avesani CM; Bezerra FF
Nutrition; 2024 Apr; 120():112351. PubMed ID: 38330891
[TBL] [Abstract][Full Text] [Related]
8. Phase angle as a marker for muscle abnormalities and function in patients with colorectal cancer.
Souza NC; Avesani CM; Prado CM; Martucci RB; Rodrigues VD; de Pinho NB; Heymsfield SB; Gonzalez MC
Clin Nutr; 2021 Jul; 40(7):4799-4806. PubMed ID: 34271241
[TBL] [Abstract][Full Text] [Related]
9. Associations of muscle and adipose tissue parameters with long-term outcomes in middle and low rectal cancer: a retrospective cohort study.
Liu J; Yu X; Huang X; Lai Q; Chen J
Cancer Imaging; 2023 Jan; 23(1):5. PubMed ID: 36635737
[TBL] [Abstract][Full Text] [Related]
10. Muscle loss during primary debulking surgery and chemotherapy predicts poor survival in advanced-stage ovarian cancer.
Huang CY; Yang YC; Chen TC; Chen JR; Chen YJ; Wu MH; Jan YT; Chang CL; Lee J
J Cachexia Sarcopenia Muscle; 2020 Apr; 11(2):534-546. PubMed ID: 31999069
[TBL] [Abstract][Full Text] [Related]
11. Skeletal muscle gauge as a prognostic factor in patients with colorectal cancer.
Park IK; Yang SS; Chung E; Cho ES; Lee HS; Shin SJ; Im YC; Park EJ; Baik SH; Lee KY; Kang J
Cancer Med; 2021 Dec; 10(23):8451-8461. PubMed ID: 34643052
[TBL] [Abstract][Full Text] [Related]
12. The relationship between computed tomography-derived body composition, systemic inflammatory response, and survival in patients undergoing surgery for colorectal cancer.
Dolan RD; Almasaudi AS; Dieu LB; Horgan PG; McSorley ST; McMillan DC
J Cachexia Sarcopenia Muscle; 2019 Feb; 10(1):111-122. PubMed ID: 30460764
[TBL] [Abstract][Full Text] [Related]
13. Computed tomography-determined skeletal muscle density predicts 3-year mortality in initial-dialysis patients in China.
Sheng MJ; Cao JY; Hou SM; Li M; Wang Y; Fang Q; Miao AF; Yang M; Liu SS; Hu CH; Liu CL; Wang SY; Zheng J; Xiao JJ; Zhang XL; Liu H; Liu BC; Wang B
J Cachexia Sarcopenia Muscle; 2023 Dec; 14(6):2569-2578. PubMed ID: 37722854
[TBL] [Abstract][Full Text] [Related]
14. The impact of skeletal muscle abnormalities on tolerance to adjuvant chemotherapy and radiation and outcome in patients with endometrial cancer.
Ganju RG; TenNapel M; Spoozak L; Chen AM; Hoover A
J Med Imaging Radiat Oncol; 2020 Feb; 64(1):104-112. PubMed ID: 31397078
[TBL] [Abstract][Full Text] [Related]
15. Association of Low Muscle Mass and Low Muscle Radiodensity With Morbidity and Mortality for Colon Cancer Surgery.
Xiao J; Caan BJ; Cespedes Feliciano EM; Meyerhardt JA; Peng PD; Baracos VE; Lee VS; Ely S; Gologorsky RC; Weltzien E; Kroenke CH; Kwan ML; Alexeeff SE; Castillo AL; Prado CM
JAMA Surg; 2020 Oct; 155(10):942-949. PubMed ID: 32805015
[TBL] [Abstract][Full Text] [Related]
16. Effect of low skeletal muscle mass combined with low muscle strength to predict survival in patients with incurable cancer.
Calixto-Lima L; de Oliveira LC; Pimenta NG; de Albuquerque NMC; Chaves GV; Wiegert EVM
Clin Nutr ESPEN; 2022 Oct; 51():445-451. PubMed ID: 36184241
[TBL] [Abstract][Full Text] [Related]
17. Chest computed tomography-derived muscle mass and quality indicators, in-hospital outcomes, and costs in older inpatients.
Shen Y; Luo L; Fu H; Xie L; Zhang W; Lu J; Yang M
J Cachexia Sarcopenia Muscle; 2022 Apr; 13(2):966-975. PubMed ID: 35178898
[TBL] [Abstract][Full Text] [Related]
18. The relationship between the mode of presentation, CT-derived body composition, systemic inflammatory grade and survival in colon cancer.
Golder AM; Sin LKE; Alani F; Alasadi A; Dolan R; Mansouri D; Horgan PG; McMillan DC; Roxburgh CS
J Cachexia Sarcopenia Muscle; 2022 Dec; 13(6):2863-2874. PubMed ID: 36218135
[TBL] [Abstract][Full Text] [Related]
19. Sarcopenia and Skeletal Muscle Quality as Predictors of Postoperative Complication and Early Mortality in Gynecologic Cancer.
Silva de Paula N; de Aguiar Bruno K; Azevedo Aredes M; Villaça Chaves G
Int J Gynecol Cancer; 2018 Feb; 28(2):412-420. PubMed ID: 29266018
[TBL] [Abstract][Full Text] [Related]
20. Low skeletal muscle density is associated with poor survival in patients who receive chemotherapy for metastatic gastric cancer.
Hayashi N; Ando Y; Gyawali B; Shimokata T; Maeda O; Fukaya M; Goto H; Nagino M; Kodera Y
Oncol Rep; 2016 Mar; 35(3):1727-31. PubMed ID: 26648321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]